Masimo (Nasdaq: MASI) announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional ...

Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient ...

Apple, Masimo, and most importantly users all suffered from this bizarre legal wrangle. How did it get this far?

For nearly two years, Apple Watch users in the United States lived without one of the most popular health features: blood ...

Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...

Masimo ( ($MASI) ) has provided an announcement. On August 18, 2025, William Jellison resigned from the Board of Directors of Masimo Corporation, ...

Masimo (MASI) announced the FDA 510(k) clearance of expanded indications for the delta hemoglobin parameters provided with O3 Regional Oximetry.

Apple will bring back the blood oxygen measurement feature to some of its watch models via a software update after receiving ...

Apple has found a way to circumvent the ban and bring Blood Oxygen monitoring to some of its Apple Watch models in the US.

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

The company said it would issue a software update to restart the technology, which was caught up in a patent dispute.

Medtech company Masimo announced it had received FDA De Novo clearance for Opioid Halo, the company's opioid overdose alert system. The monitoring system aims to prevent overdose by alerting family ...